Php228 - The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to §35a SGB v in Germany - Oncological and Metabolic Diseases

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1122

Related search